Burning Rock Biotech Ltd Quarterly Liabilities and Equity in CNY from Q4 2019 to Q4 2023

Taxonomy & unit
us-gaap: CNY and USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Burning Rock Biotech Ltd quarterly Liabilities and Equity history and growth rate from Q4 2019 to Q4 2023.
  • Burning Rock Biotech Ltd Liabilities and Equity for the quarter ending December 31, 2023 was ¥1.04B, a 34.5% decline year-over-year.
Liabilities and Equity, Quarterly (CNY)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 1.04B -547M -34.5% Dec 31, 2023 20-F 2024-04-29
Q4 2022 1.59B -691M -30.3% Dec 31, 2022 20-F 2024-04-29
Q2 2022 1.86B Jun 30, 2022 6-K 2022-11-07
Q4 2021 2.28B -384M -14.4% Dec 31, 2021 20-F 2023-04-20
Q4 2020 2.66B +1.82B +214% Dec 31, 2020 20-F 2022-04-29
Q4 2019 848M Dec 31, 2019 20-F 2021-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.